These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 15689175)

  • 1. Carbocyclic[g]indole inhibitors of human nonpancreatic s-PLA2.
    Sawyer JS; Beight DW; Smith EC; Snyder DW; Chastain MK; Tielking RL; Hartley LW; Carlson DG
    J Med Chem; 2005 Feb; 48(3):893-6. PubMed ID: 15689175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Indole inhibitors of human nonpancreatic secretory phospholipase A2. 3. Indole-3-glyoxamides.
    Draheim SE; Bach NJ; Dillard RD; Berry DR; Carlson DG; Chirgadze NY; Clawson DK; Hartley LW; Johnson LM; Jones ND; McKinney ER; Mihelich ED; Olkowski JL; Schevitz RW; Smith AC; Snyder DW; Sommers CD; Wery JP
    J Med Chem; 1996 Dec; 39(26):5159-75. PubMed ID: 8978844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-affinity aptamers selectively inhibit human nonpancreatic secretory phospholipase A2 (hnps-PLA2).
    Bridonneau P; Chang YF; O'Connell D; Gill SC; Snyder DW; Johnson L; Goodson T; Herron DK; Parma DH
    J Med Chem; 1998 Mar; 41(6):778-86. PubMed ID: 9526554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemically induced dimerization of human nonpancreatic secretory phospholipase A2 by bis-indole derivatives.
    Zhou L; Fang C; Wei P; Liu S; Liu Y; Lai L
    J Med Chem; 2008 Jun; 51(12):3360-6. PubMed ID: 18522384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Indole inhibitors of human nonpancreatic secretory phospholipase A2. 2. Indole-3-acetamides with additional functionality.
    Dillard RD; Bach NJ; Draheim SE; Berry DR; Carlson DG; Chirgadze NY; Clawson DK; Hartley LW; Johnson LM; Jones ND; McKinney ER; Mihelich ED; Olkowski JL; Schevitz RW; Smith AC; Snyder DW; Sommers CD; Wery JP
    J Med Chem; 1996 Dec; 39(26):5137-58. PubMed ID: 8978843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-based design of the first potent and selective inhibitor of human non-pancreatic secretory phospholipase A2.
    Schevitz RW; Bach NJ; Carlson DG; Chirgadze NY; Clawson DK; Dillard RD; Draheim SE; Hartley LW; Jones ND; Mihelich ED
    Nat Struct Biol; 1995 Jun; 2(6):458-65. PubMed ID: 7664108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Indole inhibitors of human nonpancreatic secretory phospholipase A2. 1. Indole-3-acetamides.
    Dillard RD; Bach NJ; Draheim SE; Berry DR; Carlson DG; Chirgadze NY; Clawson DK; Hartley LW; Johnson LM; Jones ND; McKinney ER; Mihelich ED; Olkowski JL; Schevitz RW; Smith AC; Snyder DW; Sommers CD; Wery JP
    J Med Chem; 1996 Dec; 39(26):5119-36. PubMed ID: 9005255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A molecular modeling and 3D QSAR study of a large series of indole inhibitors of human non-pancreatic secretory phospholipase A2.
    Bernard P; Pintore M; Berthon JY; Chrétien JR
    Eur J Med Chem; 2001 Jan; 36(1):1-19. PubMed ID: 11231045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The first potent inhibitor of mammalian group X secreted phospholipase A2: elucidation of sites for enhanced binding.
    Smart BP; Oslund RC; Walsh LA; Gelb MH
    J Med Chem; 2006 May; 49(10):2858-60. PubMed ID: 16686528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacology of LY315920/S-5920, [[3-(aminooxoacetyl)-2-ethyl-1- (phenylmethyl)-1H-indol-4-yl]oxy] acetate, a potent and selective secretory phospholipase A2 inhibitor: A new class of anti-inflammatory drugs, SPI.
    Snyder DW; Bach NJ; Dillard RD; Draheim SE; Carlson DG; Fox N; Roehm NW; Armstrong CT; Chang CH; Hartley LW; Johnson LM; Roman CR; Smith AC; Song M; Fleisch JH
    J Pharmacol Exp Ther; 1999 Mar; 288(3):1117-24. PubMed ID: 10027849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein-based alignment in 3D QSAR of 26 indole inhibitors of human pancreatic phospholipase A2.
    Pintore M; Bernard P; Berthon JY; Chrétien JR
    Eur J Med Chem; 2001 Jan; 36(1):21-30. PubMed ID: 11231046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A continuous fluorescence assay for phospholipase A2 with nontagged lipid.
    Huang C; Zhou L; Liu Y; Lai L
    Anal Biochem; 2006 Apr; 351(1):11-7. PubMed ID: 16510113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative structure-activity relationship (QSAR) analysis of a series of indole analogues as inhibitor for human group V secretory phospholipase A2.
    OmPraba G; Velmurugan D
    Indian J Biochem Biophys; 2006 Jun; 43(3):154-9. PubMed ID: 16967904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-activity relationships of indole cytosolic phospholipase A(2)alpha inhibitors: substrate mimetics.
    McKew JC; Lovering F; Clark JD; Bemis J; Xiang Y; Shen M; Zhang W; Alvarez JC; Joseph-McCarthy D
    Bioorg Med Chem Lett; 2003 Dec; 13(24):4501-4. PubMed ID: 14643356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of the complete set of mammalian secreted phospholipases A(2) by indole analogues: a structure-guided study.
    Smart BP; Pan YH; Weeks AK; Bollinger JG; Bahnson BJ; Gelb MH
    Bioorg Med Chem; 2004 Apr; 12(7):1737-49. PubMed ID: 15028265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regioselective synthesis of 4- and 7-alkoxyindoles from 2,3-dihalophenols: application to the preparation of indole inhibitors of phospholipase A2.
    Sanz R; Castroviejo MP; Guilarte V; Pérez A; Fañanás FJ
    J Org Chem; 2007 Jul; 72(14):5113-8. PubMed ID: 17559277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design and synthesis of 1-indol-1-yl-propan-2-ones as inhibitors of human cytosolic phospholipase A2alpha.
    Ludwig J; Bovens S; Brauch C; Elfringhoff AS; Lehr M
    J Med Chem; 2006 Apr; 49(8):2611-20. PubMed ID: 16610804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potent inhibitors of secretory phospholipase A2: synthesis and inhibitory activities of indolizine and indene derivatives.
    Hagishita S; Yamada M; Shirahase K; Okada T; Murakami Y; Ito Y; Matsuura T; Wada M; Kato T; Ueno M; Chikazawa Y; Yamada K; Ono T; Teshirogi I; Ohtani M
    J Med Chem; 1996 Sep; 39(19):3636-58. PubMed ID: 8809154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-activity relationship studies of 1-substituted 3-dodecanoylindole-2-carboxylic acids as inhibitors of cytosolic phospholipase A2-mediated arachidonic acid release in intact platelets.
    Griessbach K; Klimt M; Schulze Elfringhoff A; Lehr M
    Arch Pharm (Weinheim); 2002; 335(11-12):547-55. PubMed ID: 12596219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of cytosolic phospholipase A2alpha: hit to lead optimization.
    McKew JC; Foley MA; Thakker P; Behnke ML; Lovering FE; Sum FW; Tam S; Wu K; Shen MW; Zhang W; Gonzalez M; Liu S; Mahadevan A; Sard H; Khor SP; Clark JD
    J Med Chem; 2006 Jan; 49(1):135-58. PubMed ID: 16392799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.